Warfarin Sensitivity Genotyping

Warfarin Anticoagulation

August 2008

Warfarin anticoagulation is utilized to decrease the risk for thrombosis and a wide variety of clinic applications such as atrial fibrillation, cardiac arrhythmias, heart valves, orthopedic surgery and thrombophilia (both genetically predisposed or acquired).

< Previous Slide

Warfarin Anticoagulation

Next Slide >

 

Jump to section:

• Introduction
• Warfarin
• Warfarin Anticoagulation
• Warfarin
• Warfarin Monitoring
• Therapeutic Graph
• INR Variability in a 74 Year-old Male
• Warfarin and Bleeding Events
• Warfarin Metabolism
• Polymorphisms and Warfarin Sensitivity
• Polymorphisms and Warfarin Sensitivity
• Summary of Polymorphisms and Warfarin Pharmacokinetics⁵
• CYP2C9 Association Study
• PGx-Guided Warfarin Dosing⁷
• Warfarin Pharmacodynamics
• Polymorphisms and Warfarin Sensitivity
• VKORC1 Promoter Polymorphism⁶
• CYP2C9 and VKORC1 Interaction⁸
• Genotype-guided Warfarin Dosing⁹
• Genotype-guided Dosing
• Summary
• Orthopedic Algorithm¹⁰
• Significant Warfarin Drug Interactions
• Differential Effect of Drugs
• Patient Case: Rapidly Increasing INR
• References
• Questions?